FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

Hahn Rejects Animal Biotech MOU

Outgoing FDA commissioner Stephen Hahn says the agency does not support a last-minute policy restriction placed on FDA involving animal genetic engine...

Federal Register

Info Collection on Drug Communications Supporting Data

Federal Register notice: FDA sends to OMB an information collection extension entitled Data to Support Drug Product Communications as Used by the Food...

FDA General

Politics Cant Be Kept Out of FDA: Opinion

Three University of Pennsylvania medical school health policy experts propose a way to keep necessary political involvement in FDA decisions from inte...

FDA General

Hahn Admits to White House Covid Pressure

Outgoing FDA commissioner Stephen Hahn says he was under significant White House pressure on Covid vaccines and treatments.

Human Drugs

Covid Alcohol Testing Policy

FDA issues an immediately effective guidance on methanol testing in drug products during the Covid-19 public health emergency.

Federal Register

Rule on Agency Reviews of Certain Regulations

Federal Register Final Rule: HHS issues a final rule under the Regulatory Flexibility Act that requires agencies like FDA to publish plans to conduct ...

Human Drugs

FDA Lifts Hold on Pieris Pharma Clinical Trial

FDA removes a partial clinical hold on a Pieris Pharmaceuticals Phase 1 study of PRS-343 that was issued while the company conducted an additional in-...

FDA Advanced Manufacturing Collaboration with NIST

FDA commissioner Stephen Hahn and senior advisor Colin Rom say a new collaborative effort with the National Institute of Standards and Technology will...

Human Drugs

FDA Releases 39-Page Lupin FDA-483

DA releases a 39-page FDA-483 with 13 observations issued following a lengthy inspection at Lupins Somerset, NJ, drug manufacturing facility.

Human Drugs

Janssen Accelerated Approval for Darzalex Faspro

FDA grants accelerated approval to Janssen Biotechs Darzalex Faspro (daratumumab plus hyaluronidase) for combination use with bortezomib, cyclophospha...